FundedIQ
Biotechnology

TômTex Co: Funding, Investors & Team (Oct 2026)

We are plastic-free and 100% naturally biodegradable alternative to synthetic and animal leathers. TômTex is a revolutionary, bio-based, high-performance material created from Biopolymer from seashell or mushroom waste. TômTex Series M (Mushroom Chitosan) TômTex Series WS (Waste Seashell Chitosan) At TômTex, our mission is to create innovative material designs that parallel lifecycles observed in nature and serve as alternatives to the production methods that have contributed to our world’s environmental crisis. Our revolutionary bio-based materials offer a sustainable, accessible, and practical alternative to currently available commercial material options.

www.tomtex.co LinkedIn New York, United States 11-50 employees
Total raised
$2.3M
Rounds
1
Latest
Seed
Nov 2023

TômTex Co has raised $2.3M across 1 funding round on record, the most recent a Seed of $2.3M announced in Nov 2023.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

TômTex Co Company Profile and Key Stats

Total funding raised
$2.3M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$2.3M in Nov 2023
Employees
11-50
reported band
Headquarters
New York, United States

Latest funding round on record: Nov 2023.

TômTex Co Funding Rounds

Date
Round
Amount
Seed
$2.3M

TômTex Co Founders and Leadership Team

Name
Role
Contact
Uyen Tran
CEO
—

No contact details are on record for this team yet.

TômTex Co Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
17,153
$3.1M

TômTex Co's latest round of $2.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like TômTex Co in Biotechnology and New York

Companies Similar to TômTex Co

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

TômTex Co Funding FAQs

What does TômTex Co do?

We are plastic-free and 100% naturally biodegradable alternative to synthetic and animal leathers. TômTex is a revolutionary, bio-based, high-performance material created from Biopolymer from seashell or mushroom waste. TômTex Series M (Mushroom Chitosan) TômTex Series WS (Waste Seashell Chitosan) At TômTex, our mission is to create innovative material designs that parallel lifecycles observed in nature and serve as alternatives to the production methods that have contributed to our world’s environmental crisis. Our revolutionary bio-based materials offer a sustainable, accessible, and practical alternative to currently available commercial material options.

How much funding has TômTex Co raised?

TômTex Co has raised $2.3M across 1 round on record. The most recent is a Seed of $2.3M announced in Nov 2023.

When did TômTex Co last raise funding?

TômTex Co's most recent funding round on record is a Seed of $2.3M, announced in Nov 2023.

Who is the CEO of TômTex Co?

Uyen Tran is listed as CEO at TômTex Co.

Where is TômTex Co headquartered?

TômTex Co is based in New York, United States.

How many employees does TômTex Co have?

TômTex Co is in the 11-50 employee band.

How does TômTex Co's funding compare to other Biotechnology startups?

TômTex Co's latest round of $2.3M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's TômTex Co Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TômTex Co is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.